Canine
Parvovirus
- (CPV-@) (MLV)
|
Administer at
6-8 wks of age, then every 3-4 wks until 12-14 weeks of
age |
PARVOVIRUS
Two doses, 3-4 weeks apart. One
dose is considered protective and acceptable |
After a booster
at 1 yr (unless mfg. label recommends otherwise) revaccination
once every 3 yrs or more is considered protective |
Core:
Although annual boosters are recommended by some vaccine
mfg. studies have shown protection against challenge (DOI)up
to 7 yrs posst vaccination with MLVvaccine products with
CPV-2 all provide excellent protection against field
isolates. |
Canine
Parvovirus
- CPV-2 (killed)
|
|
|
|
Not
recommended killed parvovirus products have been
shown to be susceptible to maternal antibody
interference in puppies as old as 16-18 wks .
Multiple doses (2-5) may be required even if puppies
oldaer than 12 wks |
Canine
Distemper
- Virus (CDV) (MLV)
|
Administer at
6-8 wks of age, then every 3-4 wks until 12-14 wks of
age |
DISTEMPER
Two doses , 3-4 weeks apart. One
dose is considered protective and acceptable. |
After a booster
at 1 yr (unless mfg recommends)revaccination once
every 3 yrs or more is considered protective. |
Core:
Although annual boosters are recommended by some mfg ,
adult dogs, challenged 7 yrs following vacinnation were
protected |
Canine
Distemper
- Virus (rCDV)
|
Administer at
6-8 wks of age, the 3-4 wks apart until 12-14 wks of age |
DISTEMPER
Two doses-3-4 wks apart |
After a booster
at 1 yr revaccination
every 3 yrs is protective |
A suitable
alternative to the MLV-CDV vaccine Recent studies have
shown compared with MLV_CDV vaccines the recomvinant CDV
is more likely to immunize puppies in the face of
passively acquired maternal antibody |
Distemper-
- Measles Virus
- (D-MV)(MLV)
|
One dose only
between 4-12 wks |
MEASLES
Never indicated in animals older than
12 wks |
Never
indicated in animals older than 12 wks |
Noncore:
Intended to provide temporary protection in
- puppies because the measles vaccine
is effective at providing immunity against CDV even
in the presence of passively acquired maternal
antibody
|
| Canine
Adenovirus-1(Cav-1) (MLV) and killed |
|
|
|
Not
recommended : Significant risk of "hepatitis
blue-eye reactions is associated with CAV-1 vaccines.
CAV-2 vaccines very effectively cross-protect against
CAV-1 and are much safer. |
| Canine
Adenovirus-2(CAV-2) (MLV parenteral) |
Administer at
6-8 wks of age, then every 3-4 wks until 12-14 wks |
ADENOVIRUS
Two doses 3-4 wks apart. One
dose is considered protective |
After a booster
at 1 yr revaccination once every 3
yrs or more is considered protective. |
Core:
Demonstrated cross-protection against canine hepatitis
caused by CAV-1 as well as CAV-2 one of the agents
- known to be associated with
infectious tracheobronchitis. Adult dogs challenged
7 yrs following vaccination were protected
|
| Canine
Adenovirus-2 (CAV-2) killed or topical |
|
|
|
Not
recommended. CAV-2 (MLVparenteral) vaccines
- produce a more effective immune
response than CAV-2 killed vaccines do.
|
| Rabies 1-year
killed |
Administer one
dose as early as 3 months of age |
RABIES-1YR
Administer a single dose |
Annually,
State and local laws apply. The 1-yr rabies
vaccine may be used as booster vaccine when dogs are
required by statute to be vaccinated annually. |
State, and
local statutes govern the frequency of vacciness for
products labeled as 1 yr vaccines. The 1 yr rabies
vaccine is sometimes administered as the initial dose
followed by a 1 year later by administration of the 3 yr
rabies vaccine. State statute governs. 1 yr
vaccine should not be considered to cause fewer adverse
reactions than a 3 yr rabies products. Route of
administration is not optional. |
| Rabies-3 yr
killed |
Administer one
dose as early as 3 months of age where authorized by law
a 3 yr vaccine may be substituted as alternative to the
1 yr vaccine for intial and subsequent doses |
RABIES-3YR
Administer a single dose. Where
authorized by local and state statures a 3 yrrabies
vaccine may be substituted as an alternative to
the 1 yr vaccine for intial and subsequent doses. |
The second
rabies vaccination is recommended 1 year following the
adminsitration fo the initial dose regardless of the
animals age at the time the first dose was given .
Booster vaccines
should be given every 3 yrs. State and local laws may
apply |
State and local
laws govern statutes the frequency of giving the 3 yrs
rabies vaccine. The 1 yr vaccine is sometimes
given as the initial dose follwoed 1 yr later by the 3
yr rabies vaccine. |
| Parainfluenza
Virus (CPIV) (MLV parenteral) |
Administer at
6-8 wks of age then every 3-4 wks until 12-14 wks of age |
One dose is
adequate. |
After a booster
at 1 yr revaccination once
every 3 years is protective. |
DOI by
challenge has been shown to be at least 1 yr for topical
intranasal vaccine. |
| Bordetella
bronchiseptica)killed bacterin-parental) |
Administer one
dose at 6-8 wks and one dose at 1-12 wks of age |
KENNEL
COUGH
Two doses 2-4 weeks apart. |
Annually
or more often in very high -risk animals not protected
by annual booster. |
There is no
known advantage to giving parenteral and intrranasal B
vaccines simultaneously. Vaccine should be given
at least 1 wk prior to exposure. |
| Bordetella
bronchiseptica(live arirulent bacteria) + Parainfluenza
?Virus (MLV) topical intranasal application |
Administer a
single dose as early as 3 wks of age for best results a
second dose should be given 2-4 wks after the first |
KENNEL
COUGH
A single dose is recommended |
Annually.
or more often in very high -risk animals not protected
by annual boosters |
Transient 3-10
coughing, sneezing, or nasal discharge may occur in
small percentage of vaccinates. If animal has not
been vaccinated within the previous 6 months a booster
is recommended 1 week prior to known exposure. |
| Bordetella
bronchiseptica(cell wall antigen extract)parenteral |
Administer one
dose at 8 wks of age and one dose at 12 weeks of age |
KENNEL
COUGH
Two doses 4 weeks apart |
Annually
or up to every 6 months in high risk environments |
DOI is apprx.
9-12 months There is no known advantage to giving
parenteral and internasal simultaneously. |
| Bomelia (Lyme)
killed whole bacteria |
Intital dose
may be given at 9-12 wks of age with a 2nd dose 2-4 wks
later |
LYME
DISEASE FROM TICKS
Two doses 2-4 wks apart |
Annually
Revaccinate prior to start of tick season as determined
by region |
Recommended
only for use in dogs that known high risk of exposure
living in an area where tick exposure is high.
Minimum challenge is 1 yr in studies |
| Canine
Doronavirus (CCV) (killed and MLV) |
|
|
|
Not
recommended--Prevalence of clinical cases of
confirmed CCV disease does not justify vaccination.
Clinical disease rarely occurs and when seen is
typically mild and self-limiting. Experience has
shown no additional increase in infectious erteritis
amoung adults or puppies subsequent to discontinuing CCV
vaccines Neither the MLV vaccine nor the
killed CCV vaccine have been shown to protect dogs
against challenge when these tow viruses are used |
| Leptospira
interrogans(combined with serovars canicola and
icterohaemorrhaglae killed bacteria) |
Administer one
dose at 12 wks and one dose at 14-16 wks for optimal
response. Do not give to dogs younger than 12
weeks. |
Two doses 2-4
wks apart. |
Annual boosters
are not
routinely recommended for all dogs. Vaccinations
should be restricted to use in areas where a reasonable
risk of exposure is established. Vets are advised
of anecdotal reports of acute anaphylaxis in toy breeds
following adminstration of leptospirosis vaccines.
Routine vaccination of toy breeds should only be
considered in dogs with known high risks. Dogs at
high risk should be vaccinated at 12and 16wks of age.and
then at intervals of 6-9 months until the risk is
reduced. |
Disease
prevalence is likely to vary for each serovar.
Vaccine recommendations are therefore difficult to make
die to lack of information on prevalence of specific
serovar infections in fogs in various geographic
regions. Anecdotal reports from vets and breeders
suggest that incidence of post vaccination reactions
(acute anaphylaxis) in puppies (<12 wks of age ) and
small breed dogs is high. Reactions are most
severe in young puppies. Therefore, routine use of
the vaccine should be delayed until dogs are 12 wks of
age. Minimum DOI based on challenge studies has
been shown to be approx 1 year for serovars. |
| Giardia |
|
|
|
Not
recommended the vaccine may prevent cyst shedding
but does not prevent infection. There is
insufficient date to warrant routine use of this
vaccine. |
| Crotalus atrox
Toxid |
|
|
|
used to protect
dogs against venom of snake bite and should be used only
in areas associated with rattlesnakes |
Porphyromonas
- peridontal disease
|
|
|
|
intended ONLY
as an act to prevent peridontal disease in dogs |
